To compare dose to organs at risk (OARs) and dose-escalation possibility for 24 stage I non-small cell lung cancer (NSCLC) patients in a ROCOCO (Radiation Oncology Collaborative Comparison) trial.
from Imaging via alkiviadis.1961 on Inoreader http://ift.tt/2DmTDhX
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου